CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-19 | ECKERT ROBERT Director | Grant or award | +665 | 26,251 | ||
| 2025-05-23 | ECKERT ROBERT Director | Grant or award | +809 | 25,027 | ||
| 2024-05-31 | ECKERT ROBERT Director | Grant or award | +719 | 23,715 | ||
| 2023-05-19 | ECKERT ROBERT Director | Grant or award | +939 | 22,465 | ||
| 2022-08-18 | ECKERT ROBERT Director | Sale | −6,600 | $249.00 | $1.6M | 21,184 |
| 2022-08-10 | ECKERT ROBERT Director | Option exercise | +20,000 | $85.59 | $1.7M | 34,575 |
| 2022-08-10 | ECKERT ROBERT Director | Shares withheld for taxes | −6,791 | $252.09 | $1.7M | 27,784 |
| 2022-08-10 | ECKERT ROBERT Director | Option exercise · Nqso (Right to Buy) | −20,000 | 0 | ||
| 2022-05-17 | ECKERT ROBERT Director | Grant or award | +855 | 14,461 | ||
| 2021-05-18 | ECKERT ROBERT Director | Grant or award | +837 | 13,199 |
Page 1 of 1 · 10 trades